Kolexia
Trouilloud Isabelle Gastro-entérologie
Trouilloud Isabelle
Gastro-entérologie
Hôpital Saint-Antoine
Paris, France
83 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs du pancréas Tumeurs colorectales Instabilité des microsatellites Tumeurs du côlon Carcinomes Métastase tumorale Tumeurs colorectales héréditaires sans polypose Tumeurs de l'estomac

Collaborateurs

Voir plus
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France
Coriat Romain
Coriat Romain
Hôpital Cochin, Paris, France
Afchain Pauline
Afchain Pauline
Hôpital Saint-Antoine, Paris, France
Andre Thierry
Andre Thierry
Hôpital Saint-Antoine, Paris, France

Industries

Voir plus
Servier
4 collaboration(s)
Dernière en 2023
Ipsen
2 collaboration(s)
Dernière en 2021
Amgen
2 collaboration(s)
Dernière en 2021
Erytech Pharma
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
625P Efficacy and safety of the combination of encorafenib and cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: An AGEO real-world multicentre study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
SO-8 Predictive values of blood-based RNA signature for the FOLFIRINOX/FOLFOX response in advanced pancreatic cancer
Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023   01 juin 2023
Digital tool to identify and monitor regorafenib-associated hand-foot skin reactions: A proof-of-concept study protocol.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   20 mai 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
Journal of gastrointestinal oncology   10 avril 2023
TEDOPAM: A Randomized Non-comparative Phase II Study of Maintenance Therapy With OSE2101 Plus FOLFIRI, or FOLFIRI After Induction Therapy With FOLFIRINOX in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (TEDOPaM-D17-01 PRODIGE 63 Study)
Essai Clinique (Ose Immunotherapeutics)   24 février 2023
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study.
International journal of cancer   03 janvier 2023
A randomized, non-comparative, phase II study of maintenance OSE2101 vaccine alone or in combination with nivolumab (nivo) or FOLFIRI after induction with FOLFIRINOX in patients (Pts) with advanced pancreatic ductal adenocarcinoma (aPDAC): First interim results of the TEDOPAM GERCOR D17-01 PRODIGE 63 STUDY.
2022 ASCO Annual Meeting I   02 juin 2022
Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study".
Clinical colorectal cancer   14 février 2022
Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with advanced pancreatic adenocarcinoma (NCT03665441).
2022 ASCO Gastrointestinal Cancers Symposium   19 janvier 2022
Monitoring levels of circulating cell-free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment.
Molecular oncology   22 juin 2021